» Articles » PMID: 36456742

Effects of Co-exposure to Fluoride and Arsenic on TRAF-6 Signaling and NF-κB Pathway Of Bone Metabolism

Overview
Date 2022 Dec 1
PMID 36456742
Authors
Affiliations
Soon will be listed here.
Abstract

Little is known about the combined effect of fluoride (F) and arsenic (As) on bone metabolism. This study aims to explore the effect of co-exposure to F and As on the expressions of TNF receptor-associated factor 6 (TRAF-6), nuclear factor-kappa B (NF-κB), and the related factors in cell and animal experiments. With the rats exposed to different doses of F, As, and combined F-As, we found that F exposure doses were positively correlated with the protein expression of receptor activator of nuclear factor-kappa B ligand (RANKL), receptor activator of nuclear factor-kappa B (RANK), TRAF-6, NF-κB, and nuclear factor of activated T cells (NFAT-c1) (P < 0.001). As exposure doses were negatively correlated with RANK, TRAF-6, NF-κB, and NFAT-c1 (P < 0.001). The effect of F and As interaction on the protein expression of RANKL, TRAF-6, NF-κB, and NFAT-c1 was significant in bone tissue (P < 0.05). In the cellular experiment, F could promote the mRNA expression of RANK, TRAF-6, and NFAT-c1. A higher concentration of As could inhibit the mRNA expression of Tartrate-resistant acid phosphatase (TRAP), RANK, TRAF-6, and NFAT-c1. The effect of F and As interaction on the mRNA expression of TRAP, RANK, TRAF-6, and NFATc1 in osteoclasts was significant (P < 0.001). In conclusion, the expression of TRAF-6 and NF-κB pathway was affected by F and As co-exposure in osteogenic differentiation, and As could antagonize the promoting effect of F on the expression of TRAF-6, TRAP, RANKL, RANK, NF-κB, and NFAT-c1 in these exposure levels. These results could provide a scientific basis for understanding the interaction of F and As in bone formation.

Citing Articles

TRAF1 promotes osteoclastogenesis by enhancing metabolic adaptation to oxidative phosphorylation in an AKT-dependent manner.

Kang H, Peng R, Dong Y, Dong Y, Liao F, Zhu M Mol Ther. 2025; 33(3):933-949.

PMID: 39863932 PMC: 11897774. DOI: 10.1016/j.ymthe.2025.01.040.


Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.

Zheng H, Liu Y, Deng Y, Li Y, Liu S, Yang Y Mol Med. 2024; 30(1):20.

PMID: 38310228 PMC: 10838448. DOI: 10.1186/s10020-024-00788-w.

References
1.
Gonzalez-Horta C, Ballinas-Casarrubias L, Sanchez-Ramirez B, Ishida M, Barrera-Hernandez A, Gutierrez-Torres D . A concurrent exposure to arsenic and fluoride from drinking water in Chihuahua, Mexico. Int J Environ Res Public Health. 2015; 12(5):4587-601. PMC: 4454927. DOI: 10.3390/ijerph120504587. View

2.
Podgorski J, Berg M . Global threat of arsenic in groundwater. Science. 2020; 368(6493):845-850. DOI: 10.1126/science.aba1510. View

3.
Yadav A, Kaushik C, Haritash A, Kansal A, Rani N . Defluoridation of groundwater using brick powder as an adsorbent. J Hazard Mater. 2005; 128(2-3):289-93. DOI: 10.1016/j.jhazmat.2005.08.006. View

4.
Wang W, Xu J, Liu K, Liu X, Li C, Cui C . Suppression of Sclerostin and Dickkopf-1 levels in patients with fluorine bone injury. Environ Toxicol Pharmacol. 2013; 35(3):402-7. DOI: 10.1016/j.etap.2013.01.005. View

5.
Nakamoto T, Rawls H . Fluoride Exposure in Early Life as the Possible Root Cause of Disease In Later Life. J Clin Pediatr Dent. 2018; 42(5):325-330. DOI: 10.17796/1053-4625-42.5.1. View